Article By:
Admiral Markets
Wednesday, May 26, 2021 9:39 AM EDT
During yesterday's session, Pieris Pharmaceuticals (PIRS) soared in the financial markets after reaching a collaboration agreement with Genentech, in an operation that could be valued at $1.4 billion.
In this article: PIRS